Selective targeting of KRAS mutant cancer cells by a novel small molecule compound

被引:0
|
作者
Iskandar, Kartini [1 ]
Rezlan, Majidah [1 ]
Yadav, Sanjiv K. [1 ]
Pervaiz, Shazib [1 ]
机构
[1] Natl Univ Singapore, Singapore 117548, Singapore
关键词
D O I
10.1158/1538-7445.AM2014-2605
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2605
引用
收藏
页数:1
相关论文
共 50 条
  • [41] Identification of novel and selective small molecule scaffolds targeting the Aurora Kinase Family
    Mohney, Robert P.
    Chen, Ke
    Williams, Kevin P.
    Cheatham, Lynn A.
    Murray, Jeffrey
    Vandecarr, Gretchen
    Galasinski, Scott
    Licause, Joe
    Janzen, William P.
    Hodge, C. Nicholas
    CANCER RESEARCH, 2006, 66 (08)
  • [42] Selective inhibition of cancer metastasis with a novel small therapeutic molecule
    Xu, Li
    Farmer, Rebecca
    Huang, Xiaoke
    Pruell, Sean
    Voll, Eric
    Pavese, Janet
    Valsecchi, Matias
    Biddle, Margaret
    Nibbs, Antoinette
    Avram, Michael
    Scheidt, Karl A.
    Bergan, Raymond C.
    CANCER RESEARCH, 2012, 72
  • [43] Regulation of ferroptosis in KRas mutant cancer cells
    Choi, Byeong
    Colon, Tania
    Jiang, Jessica
    Lee, Eunji
    Dai, Wei
    FASEB JOURNAL, 2020, 34
  • [44] Targeting KRAS mutant lung cancer: light at the end of the tunnel
    Drosten, Matthias
    Barbacid, Mariano
    MOLECULAR ONCOLOGY, 2022, 16 (05) : 1057 - 1071
  • [45] A Central Role for Biophysics in Cancer Drug Discovery - Development of Candidate Small Molecule Inhibitors in Mutant KRas
    Gohlke, Andrea
    Bower, Justin
    Brown, Peter N.
    Cameron, Ken S.
    Drysdale, Martin
    Goodwin, Gillian
    Gray, Christopher
    Konczal, Jen
    McArthur, Duncan
    McKinnon, Heather
    Mezna, Mokdad
    Pugliese, Angelo
    Schuettelkopf, Alexander W.
    BIOPHYSICAL JOURNAL, 2018, 114 (03) : 30A - 31A
  • [46] Improve MEK/ERK targeting in mutant KRAS lung cancer
    Chen, Zhao
    Weisberg, Ellen
    Cheng, Katherine
    Kung, Andrew L.
    Bradner, James
    Griffin, James
    Wong, Kwok-Kin
    MOLECULAR CANCER RESEARCH, 2014, 12
  • [47] Inhibitor combinations targeting KRAS effector signaling in KRAS-mutant pancreatic cancer
    Cox, Adrienne D.
    Goodwin, Craig M.
    Bryant, Kirsten L.
    Dagliyan, Irem
    George, Samuel D.
    Lucas, Kelly E.
    Gautam, Prson
    Wennerberg, Krister
    Der, Channing J.
    CANCER RESEARCH, 2018, 78 (13)
  • [48] A novel small-molecule compound targeting CD147 inhibits the motility and invasion of hepatocellular carcinoma cells
    Fu, Zhi-guang
    Wang, Li
    Cui, Hong-yong
    Peng, Jian-long
    Wang, Shi-jie
    Geng, Jie-jie
    Liu, Ji-de
    Feng, Fei
    Song, Fei
    Li, Ling
    Zhu, Ping
    Jiang, Jian-li
    Chen, Zhi-nan
    ONCOTARGET, 2016, 7 (08) : 9430 - 9448
  • [49] Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH
    Yun, Jihye
    Mullarky, Edouard
    Lu, Changyuan
    Bosch, Kaitlyn N.
    Kavalier, Adam
    Rivera, Keith
    Roper, Jatin
    Chio, Iok In Christine
    Giannopoulou, Eugenia G.
    Rago, Carlo
    Muley, Ashlesha
    Asara, John M.
    Paik, Jihye
    Elemento, Olivier
    Chen, Zhengming
    Pappin, Darryl J.
    Dow, Lukas E.
    Papadopoulos, Nickolas
    Gross, Steven S.
    Cantley, Lewis C.
    SCIENCE, 2015, 350 (6266) : 1391 - 1396
  • [50] Implication of targeting YAP1 in KRAS-mutant lung cancer cells.
    Shimomura, Iwao
    Yamamoto, Yusuke
    Tada, Yuji
    Tatsumi, Koichiro
    Ochiya, Takahiro
    MOLECULAR CANCER RESEARCH, 2020, 18 (08) : 39 - 40